266 related articles for article (PubMed ID: 20818790)
1. Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders.
Kang YJ; Digicaylioglu M; Russo R; Kaul M; Achim CL; Fletcher L; Masliah E; Lipton SA
Ann Neurol; 2010 Sep; 68(3):342-52. PubMed ID: 20818790
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of erythropoietin against ketamine-induced apoptosis in cultured rat cortical neurons: involvement of PI3K/Akt and GSK-3 beta pathway.
Shang Y; Wu Y; Yao S; Wang X; Feng D; Yang W
Apoptosis; 2007 Dec; 12(12):2187-95. PubMed ID: 17952604
[TBL] [Abstract][Full Text] [Related]
3. Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I.
Digicaylioglu M; Garden G; Timberlake S; Fletcher L; Lipton SA
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9855-60. PubMed ID: 15210945
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage.
Digicaylioglu M; Kaul M; Fletcher L; Dowen R; Lipton SA
Neuroreport; 2004 Apr; 15(5):761-3. PubMed ID: 15073510
[TBL] [Abstract][Full Text] [Related]
5. IGF-I protects cortical neurons against ceramide-induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl-2?
Willaime-Morawek S; Arbez N; Mariani J; Brugg B
Brain Res Mol Brain Res; 2005 Dec; 142(2):97-106. PubMed ID: 16290312
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of insulin-like growth factor-I providing neuroprotection after spinal cord injury in rats.
Hung KS; Tsai SH; Lee TC; Lin JW; Chang CK; Chiu WT
J Neurosurg Spine; 2007 Jan; 6(1):35-46. PubMed ID: 17233289
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
9. Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.
Kim B; Sullivan KA; Backus C; Feldman EL
Antioxid Redox Signal; 2011 May; 14(10):1829-39. PubMed ID: 21194385
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation.
Fletcher L; Kohli S; Sprague SM; Scranton RA; Lipton SA; Parra A; Jimenez DF; Digicaylioglu M
J Neurosurg; 2009 Jul; 111(1):164-70. PubMed ID: 19284235
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.
Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG
Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factor-mediated enteric neuronal survival involves glycogen synthase kinase-3beta phosphorylation and coupling with 14-3-3.
Mwangi S; Anitha M; Fu H; Sitaraman SV; Srinivasan S
Neuroscience; 2006 Nov; 143(1):241-51. PubMed ID: 16996218
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms.
Zhang F; Signore AP; Zhou Z; Wang S; Cao G; Chen J
J Neurosci Res; 2006 May; 83(7):1241-51. PubMed ID: 16511866
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis.
Dou H; Birusingh K; Faraci J; Gorantla S; Poluektova LY; Maggirwar SB; Dewhurst S; Gelbard HA; Gendelman HE
J Neurosci; 2003 Oct; 23(27):9162-70. PubMed ID: 14534250
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
Li BG; Hasselgren PO; Fang CH
Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
18. Vascular neuroprotection via TrkB- and Akt-dependent cell survival signaling.
Guo S; Som AT; Waeber C; Lo EH
J Neurochem; 2012 Nov; 123 Suppl 2(Suppl 2):58-64. PubMed ID: 23050643
[TBL] [Abstract][Full Text] [Related]
19. NMDA neuroprotection against a phosphatidylinositol-3 kinase inhibitor, LY294002 by NR2B-mediated suppression of glycogen synthase kinase-3beta-induced apoptosis.
Habas A; Kharebava G; Szatmari E; Hetman M
J Neurochem; 2006 Jan; 96(2):335-48. PubMed ID: 16300633
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway.
Wu Y; Shang Y; Sun S; Liang H; Liu R
Apoptosis; 2007 Aug; 12(8):1365-75. PubMed ID: 17508273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
